中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 11
Nov.  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(11): 2317-2322

Clinical and pathological features of patients with congenital hepatic fibrosis： An analysis of 26 cases

DOI: 10.12449/JCH251118
  • 1.

    Department of Pathology，China-Japan Friendship Hospital，Beijing 100029，China

  • 2.

    Department of Infectious diseases，China-Japan Friendship Hospital，Beijing 100029，China

  • 3.

    Department of Gastroenterology，The 940 Hospital of Joint Logistic Support Force of PLA，Lanzhou 730050，China

Research funding:

National High Level Hospital Clinical Research Funding (2024-NHLHCRF-PYII-14)

More Information
  • Corresponding author: WANG Xiuhong， doc_wang2008@126.com （ORCID： 0009-0003-0938-1313）
  • Received Date: 2025-05-18
  • Accepted Date: 2025-07-29
  • Published Date: 2025-11-25
    Abstract
  •   Objectives  To summarize the clinical and pathological features of patients with congenital liver fibrosis （CHF）， and to investigate the differences in clinical and pathological features between patients in different age groups.  Methods  A retrospective analysis was performed for the clinicopathological data of 26 patients with pathologically confirmed CHF in China-Japan Friendship Hospital from August 2005 to June 2023， and the patients were stratified by age to investigate the clinical and pathological features of patients in different age groups.  Results  Among the 26 patients， there were 12 male patients and 14 female patients， with an age of onset of 4 — 61 years. There were 19 patients with portal hypertension type （73.08%）， 2 patients with cholangitis type （7.69%）， 4 patients with mixed type （15.38%）， and 1 patient with occult type （3.85%）. Of all 26 patients， 4 had unknown clinical symptoms， and among the 22 patients with clear clinical symptoms， 10 （45.45%） attended the hospital due to upper gastrointestinal bleeding caused by portal hypertension. Pathological manifestations included roughly normal liver parenchyma separated by fibrous septa in the portal area， with the presence of abnormal reactive bile duct hyperplasia. Denser fibrous septa and a lack of portal veins with the corresponding caliber were observed in 4 pediatric patients with disease onset before the age of 10 years， with a significant reduction or even disappearance of compensatory thin-walled blood vessels.  Conclusion  Portal hypertension-type CHF is the most common type in clinical practice. Patients with an early age of onset have certain histopathological features of the liver， with the presence of serious complications associated with portal hypertension. Therefore， liver biopsy should be performed for patients suspected of CHF in clinical practice， and genetic testing should be performed when necessary. Early identification and diagnosis are of great importance for improving the prognosis of patients.

     

    • FullText(HTML)
  • loading
    • References(16)
  • [1]
    LASAGNI A, CADAMURO M, MORANA G, et al. Fibrocystic liver disease: Novel concepts and translational perspectives[J]. Transl Gastroenterol Hepatol, 2021, 6: 26. DOI: 10.21037/tgh-2020-04.
    [2]
    WU X, ZHOU C, LUO SQ. Congenital hepatic fibrosis: Clinical features of different clinical types in 75 patients[J]. Chin Hepatol, 2014, 19( 7): 479- 482, 490. DOI: 10.14000/j.cnki.issn.1008-1704.2014.07.002.

    吴欣, 周超, 罗生强. 先天性肝纤维化不同分型的临床特征: 75例分析[J]. 肝脏, 2014, 19( 7): 479- 482, 490. DOI: 10.14000/j.cnki.issn.1008-1704.2014.07.002.
    [3]
    CHEN IY, WHITNEY-MILLER CL, LIAO XY. Congenital hepatic fibrosis and its mimics: A clinicopathologic study of 19 cases at a single institution[J]. Diagn Pathol, 2021, 16( 1): 81. DOI: 10.1186/s13000-021-01142-y.
    [4]
    ALSOMALI MI, YEARSLEY MM, LEVIN DM, et al. Diagnosis of congenital hepatic fibrosis in adulthood[J]. Am J Clin Pathol, 2020, 153( 1): 119- 125. DOI: 10.1093/ajcp/aqz140.
    [5]
    JIANG L, FANG PP, WEEMHOFF JL, et al. Evidence for a“pathogenic triumvirate” in congenital hepatic fibrosis in autosomal recessive polycystic kidney disease[J]. BioMed Res Int, 2016, 2016: 4918798. DOI: 10.1155/2016/4918798.
    [6]
    DORVAL G, BOYER O, COUDERC A, et al. Long-term kidney and liver outcome in 50 children with autosomal recessive polycystic kidney disease[J]. Pediatr Nephrol, 2021, 36( 5): 1165- 1173. DOI: 10.1007/s00467-020-04808-9.
    [7]
    LOOMES KM, RUSSO P, RYAN M, et al. Bile duct proliferation in liver-specific Jag1 conditional knockout mice: Effects of gene dosage[J]. Hepatology, 2007, 45( 2): 323- 330. DOI: 10.1002/hep.21460.
    [8]
    de KONING TJ, NIKKELS PGJ, DORLAND L, et al. Congenital hepatic fibrosis in 3 siblings with phosphomannose isomerase deficiency[J]. Virchows Arch, 2000, 437( 1): 101- 105. DOI: 10.1007/s004280000185.
    [9]
    HENDRIKSZ CJ. Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose[J]. Arch Dis Child, 2001, 85( 4): 339- 340. DOI: 10.1136/adc.85.4.339.
    [10]
    HASBAOUI B EL, RIFAI Z, SAGHIR S, et al. Congenital hepatic fibrosis: Case report and review of literature[J]. Pan Afr Med J, 2021, 38: 27941. DOI: 10.11604/pamj.2021.38.188.27941.
    [11]
    SRINATH A, SHNEIDER BL. Congenital hepatic fibrosis and autosomal recessive polycystic kidney disease[J]. J Pediatr Gastroenterol Nutr, 2012, 54( 5): 580- 587. DOI: 10.1097/mpg.0b013e31824711b7.
    [12]
    XIAO FF, WANG YZ, DONG F, et al. Congenital hepatic fibrosis in a young boy with congenital hypothyroidism: A case report[J]. World J Clin Cases, 2021, 9( 6): 1475- 1482. DOI: 10.12998/wjcc.v9.i6.1475.
    [13]
    LEUNG TM, FUNG ML, LIONG EC, et al. Role of nitric oxide in the regulation of fibrogenic factors in experimental liver fibrosis in mice[J]. Histol Histopathol, 2011, 26( 2): 201- 211. DOI: 10.14670/HH-26.201.
    [14]
    LEMOINNE S, CADORET A, RAUTOU PE, et al. Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles[J]. Hepatology, 2015, 61( 3): 1041- 1055. DOI: 10.1002/hep.27318.
    [15]
    DAI WM, LU LG, CAI XB. Relationship between hepatic sinusoidal endothelial cells and hepatic fibrosis[J]. J Clin Hepatol, 2023, 39( 2): 419- 423. DOI: 10.3969/j.issn.1001-5256.2023.02.027.

    戴伟明, 陆伦根, 蔡晓波. 肝窦内皮细胞与肝纤维化的关系[J]. 临床肝胆病杂志, 2023, 39( 2): 419- 423. DOI: 10.3969/j.issn.1001-5256.2023.02.027.
    [16]
    TANG RJ, LIU ZW, SU HB, et al. The clinical features analysis of 48 cases of congenital hepatic fibrosis[J]. Chin Hepatol, 2013, 18( 2): 75- 76. DOI: 10.14000/j.cnki.issn.1008-1704.2013.02.011.

    汤汝佳, 刘振文, 苏海滨, 等. 先天性肝纤维化48例临床特点分析[J]. 肝脏, 2013, 18( 2): 75- 76. DOI: 10.14000/j.cnki.issn.1008-1704.2013.02.011.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (7) PDF downloads(2) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return